ZFIN ID: ZDB-PERS-200103-3
Boyer, Julien
Email: julien.boyer@inserm.fr
URL:
Affiliation: Vergunst Lab
Address: INSERM U1047 / University of Montpellier 1 UFR Medecine Site de Nimes 186, Chemin du Carreau de Lanes 30908 Nimes
Country: France
Phone:
Fax:
ORCID ID:


BIOGRAPHY AND RESEARCH INTERESTS


PUBLICATIONS
Hagege, A., Saada-Bouzid, E., Ambrosetti, D., Rastoin, O., Boyer, J., He, X., Rousset, J., Montemagno, C., Doyen, J., Pedeutour, F., Parola, J., Bourget, I., Luciano, F., Bozec, A., Cao, Y., Pagès, G., Dufies, M. (2022) Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma. Cell reports. Medicine. 3:100659
Hagege, A., Ambrosetti, D., Boyer, J., Bozec, A., Doyen, J., Chamorey, E., He, X., Bourget, I., Rousset, J., Saada, E., Rastoin, O., Parola, J., Luciano, F., Cao, Y., Pagès, G., Dufies, M. (2021) The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy. Theranostics. 11:9571-9586

NON-ZEBRAFISH PUBLICATIONS
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.